See also this year's filing and all EDGAR filings for this company.
PDF Report 0001616212_2021_Trillium_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001616212, Trillium Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 298,529,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 783,000 |
| 2 | PropertyPlantAndEquipmentNet | 778,000 |
| 3 | remainder_Assets | 732,000 |
| 4 | LiabilitiesCurrent | 21,418,000 |
| 5 | LiabilitiesNoncurrent | 557,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 36,255,000 |
| 9 | ResearchAndDevelopmentExpense | 25,348,000 |
| 10 | remainder_Expenses | 102,000 |
| 11 | remainder_Revenues | 148,000 |
| 12 | remainder_NetIncome | 2,211,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 300,822,000 |
| 1 | Liabilities | 21,975,000 |
| 2 | Expenses | 61,705,000 |
| 3 | Revenues | 148,000 |
| 4 | StockholdersEquity | 278,847,000 |
| 5 | NetIncome | -59,346,000 |
| 6 | ComprehensiveNetIncome | -59,346,000 |
| 7 | BaseVar | 193,430,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.40 |
| 9 | EconomicCapitalRatio | 3.96 |
Edgar->Model Mapping
Feature Distribution
